- Genzyme to Contract Out Fill And Finish Responsibilities For Four Drugs to Hospira (Health News Daily)
This is copyright protected information, to receive the full article, please click here to sign up and register.
- FDA cancels Lilly’s Cymbalta Chronic Pain Review (Pharma Times)
- Merck, AstraZeneca Pick START to Test Anticancer Compound (San Antonio Business Journal)
- GSK Hit as France Cuts Swine Flu Jab Orders (Daily Mail)
- Merz to Acquire BioForm Medical (Pharmaceutical Processing)
- Potency drops investigated in H1N1 vaccines (Fierce Pharma Manufacturing)
- Pfizer signs deal with leading Indian CRO(PharmaTimes)